Publications by authors named "Elis Rosliza Mohd Adzemi"
Elevated serum soluble programmed death ligand 1 (sPD-L1) level correlate with clinical characteristics in breast cancer patients: A study at Hospital Universiti Sains Malaysia.
Nur Amira Khairil Anwar Muhammad Najmi Mohd Nazri Elis Rosliza Mohd Adzemi Amy Amilda Anthony Mawaddah Mohd Azlan
Cytokine
October 2024
Article Synopsis
- - The study aimed to investigate serum levels of soluble PD-L1 (sPD-L1) in breast cancer patients, specifically focusing on Asian (Malay) women, and its correlation with various clinical characteristics.
- - Blood samples were collected from 92 malignant and 16 benign breast cancer patients, as well as 23 healthy controls, revealing that sPD-L1 levels were significantly higher in the cancer groups compared to healthy individuals.
- - The findings indicated that sPD-L1 levels were linked to factors like age at menarche, ethnicity, birth control usage, and HER2 status, highlighting the need for further research on sPD-L1's role in breast cancer diagnosis and progression.
Prognostic prospect of soluble programmed cell death ligand-1 in cancer management.
Nur Amira Khairil Anwar Muhammad Najmi Mohd Nazri Ahmad Hafiz Murtadha Elis Rosliza Mohd Adzemi Venugopal Balakrishnan
Acta Biochim Biophys Sin (Shanghai)
July 2021
Aggressive tissue biopsy is commonly unavoidable in the management of most suspected tumor cases to conclusively verify the presence of cancerous cells through histological assessment. The extracted tissue is also immunostained for detection of antigens (tissue tumor markers) of potential prognostic or therapeutic importance to assist in treatment decision. Although liquid biopsies can be a powerful tool for monitoring treatment response, they are still excluded from standard cancer diagnostics, and their utility is still being debated in the scientific community.
View Article and Find Full Text PDF